Can Monsanto Company Continue to Deliver Growth to Your Portfolio?

After delivering gains of nearly 640% in the last decade, what should investors expect from Monsanto Company going forward?

Jan 29, 2014 at 8:00AM

Biotech seed producer and agricultural sciences firm Monsanto Company (NYSE:MON) has returned outsized gains to investors over its life as a public company. In fact, the company's stock has returned 640% in the last decade -- walloping the S&P 500 by more than 580% in that time. What has driven shares higher? While we can point to swelling top and bottom lines as the primary reason, we shouldn't forget that pipeline success ultimately determines growth. Can a company as mature as Monsanto continue to innovate and deliver growth in the years ahead?

Growth opportunities abound
First, let's note that investors shouldn't expect another 640% gain (not anytime soon, anyway) from a company sporting a market cap of $57 billion. That doesn't mean Monsanto is done growing, however. Consider that a record 29 of more than 70 pipeline projects advanced in development the last year. The progress included more than 10 products from the company's new technology platform and five products that were successfully commercialized. Here's how the highlights break down by platform:

Technology Platform

Pipeline Advancements

Highlighted Products



Intacta RR2 PRO soybeans, next-gen SmartStax PRO corn



Enhanced resistance to Gray Lead Spot (corn), Resistance to Bacterial Wilt (tomatoes), Downy Mildew (lettuce)



BioDirect Bee Health

Integrated Farming Systems


Weather-enhanced soybeans and corn

Source: Monsanto.

While the progress and future growth opportunities are astounding, I'll bet many readers aren't aware that Monsanto has multiple platforms. For instance, the company's breeding platform uses traditional, non-genetically modifying (well, even breeding is genetically modifying) techniques to introduce disease resistance to various crop varieties. In fact, Monsanto's breeding platform is the most advanced in the industry. Remember that the next time you tout "natural" agricultural methods.

Meanwhile, the biologicals platform works to create products that improve crop health and productivity. Monsanto is just beginning to research the technology, but it hasn't been shy about investing in it. In 2011, it made a highly criticized acquisition of bee health biotech company Beeologics, which has become an integral part of the platform today. Ironically, the company most (mistakenly) associated with colony collapse disorder, or CCD, in honey bees could become their savior. (Product candidates under development for supporting bee health are using RNAi to target two viruses that commonly target honey bees, which are the scientifically proven culprits of CCD.)

More recently, Monsanto partnered with leading industrial enzymes and microbial products company Novozymes to bolster future development of agricultural biologicals. It also made a generous $300 million upfront payment to solidify the game-changing alliance and acknowledge Novozyme's leading technology. How big is the platform's potential? The global opportunity for microbial solutions in agricultural applications stood at $2.3 billion and has grown at a mid-teen annual clip, although its a nascent field that is just beginning to grow in importance. Early adopters such as Monsanto and Novozymes stand to reap the greatest rewards.

Foolish bottom line
Monsanto has largely relied on its industry-leading biotechnology platform in the last decade. While the platform will continue to make substantial contributions going forward, the company is making significant progress with multiple complementary platforms that have amazing growth potential. Investors cannot expect every product candidate to be successfully commercialized, but there's no reason to believe long-term growth is anywhere near finished. Monsanto expects mid-to-high teens operational growth and, quite frankly, I can't disagree.

Can't invest in Monsanto? 
A company as controversial as Monsanto isn't fit for every investor, but there are other growth opportunities. And, let's face it, there's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.

Fool contributor Maxx Chatsko has no position in any stocks mentioned. Check out his personal portfolio, his CAPS pagehis previous writing for The Motley Fool, or his work for the SynBioBeta Blog to keep up with developments in the synthetic biology industry.

The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

1 Key Step to Get Rich

Our mission at The Motley Fool is to help the world invest better. Whether that’s helping people overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we can help.

Feb 1, 2016 at 4:54PM

To be perfectly clear, this is not a get-rich action that my Foolish colleagues and I came up with. But we wouldn't argue with the approach.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich" rated The Motley Fool as the #1 place online to get smarter about investing.

"The Motley Fool aims to build a strong investment community, which it does by providing a variety of resources: the website, books, a newspaper column, a radio [show], and [newsletters]," wrote (the clearly insightful and talented) money reporter Kathleen Elkins. "This site has something for every type of investor, from basic lessons for beginners to investing commentary on mutual funds, stock sectors, and value for the more advanced."

Our mission at The Motley Fool is to help the world invest better, so it's nice to receive that kind of recognition. It lets us know we're doing our job.

Whether that's helping the entirely uninitiated overcome their fear of stocks all the way to offering clear and successful guidance on complicated-sounding options trades, we want to provide our readers with a boost to the next step on their journey to financial independence.

Articles and beyond

As Business Insider wrote, there are a number of resources available from the Fool for investors of all levels and styles.

In addition to the dozens of free articles we publish every day on our website, I want to highlight two must-see spots in your tour of

For the beginning investor

Investing can seem like a Big Deal to those who have yet to buy their first stock. Many investment professionals try to infuse the conversation with jargon in order to deter individual investors from tackling it on their own (and to justify their often sky-high fees).

But the individual investor can beat the market. The real secret to investing is that it doesn't take tons of money, endless hours, or super-secret formulas that only experts possess.

That's why we created a best-selling guide that walks investors-to-be through everything they need to know to get started. And because we're so dedicated to our mission, we've made that available for free.

If you're just starting out (or want to help out someone who is), go to, drop in your email address, and you'll be able to instantly access the quick-read guide ... for free.

For the listener

Whether it's on the stationary exercise bike or during my daily commute, I spend a lot of time going nowhere. But I've found a way to make that time benefit me.

The Motley Fool offers five podcasts that I refer to as "binge-worthy financial information."

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. It's also featured on several dozen radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable ... and I don't say that simply because the hosts all sit within a Nerf-gun shot of my desk. Rule Breaker Investing and Answers contain timeless advice, so you might want to go back to the beginning with those. The other three take their cues from the market, so you'll want to listen to the most recent first. All are available at

But wait, there's more

The book and the podcasts – both free ... both awesome – also come with an ongoing benefit. If you download the book, or if you enter your email address in the magical box at the podcasts page, you'll get ongoing market coverage sent straight to your inbox.

Investor Insights is valuable and enjoyable coverage of everything from macroeconomic events to investing strategies to our analyst's travels around the world to find the next big thing. Also free.

Get the book. Listen to a podcast. Sign up for Investor Insights. I'm not saying that any of those things will make you rich ... but Business Insider seems to think so.

Compare Brokers